Potassium oxonate is one component of the anticancer drug S-1, which inhibits the toxic side effects of the antitumor drug tegafur.
Potassium oxonate is a uricase inhibitor that prevents metabolism and excretion of uric acid and induces embryotoxicity and nephrotoxicity in rats. It is a component of S-1, a mixture containing a prodrug of the antitumor agent 5-fluorouracil (5-FU; ), that suppresses the gastrointestinal toxicity of 5-FU without inhibiting its antitumor activity in rats. Formulations containing oxonic acid have been used to treat gastric, pancreatic, lung, head, neck, and breast carcinomas.
|Apperance||White to off-white crystalline powder||White crystalline powder|
|Loss on drying||≤1.0%||0.16%|
|Appearance:||White to off-white crystalline powder|
|Package details:||1kg/foil bag;25kg/drum|
High quality & competitive price
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!